FRANKFURT, May 10 (Reuters) - Scientific journal Nature on Wednesday said a personalised treatment based on messenger RNA by BioNTech (22UAy.DE) potentially bodes well for the future of fighting an extremely aggressive form of cancer after the...

Gestalt Diagnostics: PAIP 2023 Challenge Winner and MICCAI 2022 ACROBAT Challenge Winner SPOKANE, Wash., April 21, 2023 /PRNewswire/ -- Gestalt Diagnostics is honored to have taken 1st place in both International challenges. Hundreds of...

Mount Sinai: New multidisciplinary team and center of excellence deepen commitment to this complex cancer New York, NY (April 19, 2022) The Canopy Cancer Collective, a national nonprofit organization that strives to fuel better treatments and...

NEW ORLEANS – An artificial intelligence (AI) model trained using sequential health information derived from electronic health records identified a subset of individuals with a 25-fold risk of developing pancreatic cancer within three to 36...

Diagnosing pathological cancer is often a challenge, even for the most skilled clinicians. Many forms of cancer do not exhibit noticeable symptoms until the infection has progressed too far to treat effectively. Monoclonal antibodies are...

Courtesy of Clinical OMICs - Molecular Diagnostics in Personalized Medicine Johns Hopkins researchers have published new data that suggests epigenetic changes controlling how DNA operates, provides survival advantages to a subset of...